117 related articles for article (PubMed ID: 36949939)
1. Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig.
Cai DQ; Cai D; Zou Y; Chen X; Jian Z; Shi M; Lin Y; Chen J
Front Immunol; 2023; 14():1120886. PubMed ID: 36949939
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect and targets of
Yuan J; Lin M; Yang S; Yin H; Ouyang S; Xie H; Tang H; Ou X; Zeng Z
Heliyon; 2024 May; 10(10):e31137. PubMed ID: 38778969
[TBL] [Abstract][Full Text] [Related]
3. The expression profiles of signature genes from CD103
Xia ZA; Lu C; Pan C; Li J; Li J; Mao Y; Sun L; He J
BMC Med; 2023 Jul; 21(1):268. PubMed ID: 37488535
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data.
Zhu Y; Tan L; Luo D; Wang X
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535087
[TBL] [Abstract][Full Text] [Related]
5. A CD8
Lv LH; Lu JR; Zhao T; Liu JL; Liang HQ
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):53-65. PubMed ID: 35088220
[TBL] [Abstract][Full Text] [Related]
6. Construction of an oxidative stress-associated genes signature in breast cancer by machine learning algorithms.
Hu D; Qin B; Zhang L; Bu H
J Int Med Res; 2024 Mar; 52(3):3000605241232560. PubMed ID: 38520254
[TBL] [Abstract][Full Text] [Related]
7. COL12A1 as a prognostic biomarker links immunotherapy response in breast cancer.
Yan Y; Liang Q; Liu Y; Zhou S; Xu Z
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36877531
[TBL] [Abstract][Full Text] [Related]
8. The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma.
Wu Y; Du B; Lin M; Ji X; Lv C; Lai J
Sci Rep; 2023 Aug; 13(1):13415. PubMed ID: 37592010
[TBL] [Abstract][Full Text] [Related]
9. Construction of a prognostic model for breast cancer based on moonlighting genes.
Zhang M; Zhang D; Wang Q; Lin G
Hum Mol Genet; 2024 Jun; 33(12):1023-1035. PubMed ID: 38491801
[TBL] [Abstract][Full Text] [Related]
10. Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.
Yao S; Cheng TD; Elkhanany A; Yan L; Omilian A; Abrams SI; Evans S; Hong CC; Qi Q; Davis W; Liu S; Bandera EV; Odunsi K; Takabe K; Khoury T; Ambrosone CB
J Natl Cancer Inst; 2021 Aug; 113(8):1036-1043. PubMed ID: 33395700
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
[TBL] [Abstract][Full Text] [Related]
12. Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes.
Xu D; Wang Y; Chen Y; Zheng J
Cancer Immunol Immunother; 2023 Mar; 72(3):647-664. PubMed ID: 36036290
[TBL] [Abstract][Full Text] [Related]
13. Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy.
Xiong S; Zhu W; Wu L; Zhou T; Wang W; Zhang O; Xiong X; Liu Z; Luo D
Cancer Immunol Immunother; 2023 Oct; 72(10):3293-3307. PubMed ID: 37462763
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer.
Li Y; Yang X; Geng C; Liu Y; Tang T; Zhang L; Liu F; Zhang M; Hao J; Ma L
Front Immunol; 2024; 15():1390261. PubMed ID: 38726001
[TBL] [Abstract][Full Text] [Related]
15. Integrated Bioinformatics Analysis to Identify a Novel Four-Gene Prognostic Model of Breast Cancer and Reveal Its Association with Immune Infiltration.
Zhu Y; Luo J; Yang Y
Crit Rev Immunol; 2024; 44(2):1-14. PubMed ID: 38305332
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer.
Ma S; Hao R; Lu YW; Wang HP; Hu J; Qi YX
Breast Cancer (Dove Med Press); 2024; 16():199-219. PubMed ID: 38634039
[TBL] [Abstract][Full Text] [Related]
17. TJP3 promotes T cell immunity escape and chemoresistance in breast cancer: a comprehensive analysis of anoikis-based prognosis prediction and drug sensitivity stratification.
Chaojun L; Pengping L; Yanjun L; Fangyuan Z; Yaning H; Yingbo S; Qi C; Hui L
Aging (Albany NY); 2023 Nov; 15(22):12890-12906. PubMed ID: 37950731
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 5-gene-based signature to predict prognosis and correlate immunomodulators for rectal cancer.
Yi L; Qiang J; Yichen P; Chunna Y; Yi Z; Xun K; Jianwei Z; Rixing B; Wenmao Y; Xiaomin W; Parker L; Wenbin L
Transl Oncol; 2022 Dec; 26():101529. PubMed ID: 36130456
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of Golgi apparatus-related signature for predicting prognosis and immunotherapy response in breast cancer.
Chen X; Tang P; Kong Y; Chen D; Tang K
J Cancer Res Clin Oncol; 2024 Feb; 150(2):61. PubMed ID: 38300336
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma.
Oba T; Long MD; Ito KI; Ito F
Sci Rep; 2024 Jan; 14(1):2394. PubMed ID: 38287061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
